Plant ID: NPO10647
Plant Latin Name: Gentiana lactea
Taxonomy Genus: Gentiana
Taxonomy Family: Gentianaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cysteine protease | CTSV | Cathepsin L2 | O60911 | CHEMBL3272 |
Oxidoreductase | MAOA | Monoamine oxidase A | P21397 | CHEMBL1951 |
Phosphodiesterase 4 | PDE4D | Phosphodiesterase 4D | Q08499 | CHEMBL288 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0032501; multicellular organismal process | GO:1901898; negative regulation of relaxation of cardiac muscle | 3.106E-04 | 1.000E+00 | PDE4D |
BP | GO:0008152; metabolic process | GO:0042420; dopamine catabolic process | 1.242E-03 | 1.000E+00 | MAOA |
BP | GO:0050896; response to stimulus | GO:0071872; cellular response to epinephrine stimulus | 2.018E-03 | 1.000E+00 | PDE4D |
BP | GO:0008152; metabolic process | GO:0006198; cAMP catabolic process | 2.173E-03 | 1.000E+00 | PDE4D |
BP | GO:0008152; metabolic process | GO:0016540; protein autoprocessing | 2.173E-03 | 1.000E+00 | CTSV |
BP | GO:0022414; reproductive process | GO:0046697; decidualization | 3.103E-03 | 1.000E+00 | CTSV |
BP | GO:0032501; multicellular organismal process | GO:0006939; smooth muscle contraction | 7.437E-03 | 1.000E+00 | PDE4D |
BP | GO:0009987; cellular process | GO:0022617; extracellular matrix disassembly | 1.222E-02 | 1.000E+00 | CTSV |
BP | GO:0008152; metabolic process | GO:0030814; regulation of cAMP metabolic process | 1.791E-02 | 1.000E+00 | PDE4D |
BP | GO:0050896; response to stimulus | GO:0071222; cellular response to lipopolysaccharide | 1.837E-02 | 1.000E+00 | PDE4D |
BP | GO:0050896; response to stimulus | GO:0009267; cellular response to starvation | 2.082E-02 | 1.000E+00 | CTSV |
BP | GO:0009987; cellular process | GO:0050852; T cell receptor signaling pathway | 2.235E-02 | 1.000E+00 | PDE4D |
BP | Unclassified; | GO:2000021; regulation of ion homeostasis | 3.196E-02 | 1.000E+00 | PDE4D |
CC | GO:0044464; cell part | GO:0043204; perikaryon | 1.776E-02 | 1.000E+00 | CTSV |
MF | GO:0003824; catalytic activity | GO:0008131; primary amine oxidase activity | 9.316E-04 | 1.000E+00 | MAOA |
MF | GO:0003824; catalytic activity | GO:0004115; 3',5'-cyclic-AMP phosphodiesterase activity | 2.328E-03 | 1.000E+00 | PDE4D |
MF | GO:0005488; binding | GO:0030552; cAMP binding | 3.568E-03 | 1.000E+00 | PDE4D |
MF | GO:0003824; catalytic activity | GO:0003824; catalytic activity | 2.891E-02 | 1.000E+00 | CTSV, MAOA, PDE4D |
MF | GO:0003824; catalytic activity | GO:0004252; serine-type endopeptidase activity | 3.803E-02 | 1.000E+00 | CTSV |
MF | GO:0005488; binding | GO:0042277; peptide binding | 4.105E-02 | 1.000E+00 | CTSV |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09105 Amino acid metabolism | hsa00340 | Histidine metabolism | 3.596E-03 | 1.924E-02 | MAOA |
09100 Metabolism | 09105 Amino acid metabolism | hsa00360 | Phenylalanine metabolism | 2.548E-03 | 1.924E-02 | MAOA |
09100 Metabolism | 09105 Amino acid metabolism | hsa00350 | Tyrosine metabolism | 5.241E-03 | 1.924E-02 | MAOA |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 5.988E-03 | 1.924E-02 | MAOA |
09100 Metabolism | 09105 Amino acid metabolism | hsa00260 | Glycine, serine and threonine metabolism | 5.988E-03 | 1.924E-02 | MAOA |
09160 Human Diseases | 09164 Substance dependence | hsa05030 | Cocaine addiction | 7.332E-03 | 1.924E-02 | MAOA |
09160 Human Diseases | 09164 Substance dependence | hsa05031 | Amphetamine addiction | 1.002E-02 | 2.063E-02 | MAOA |
09100 Metabolism | 09105 Amino acid metabolism | hsa00330 | Arginine and proline metabolism | 7.482E-03 | 1.924E-02 | MAOA |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.031E-02 | 2.063E-02 | MAOA |
09160 Human Diseases | 09164 Substance dependence | hsa05032 | Morphine addiction | 1.359E-02 | 2.446E-02 | PDE4D |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | MAOA; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | MAOA; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Alcohol use disorders | F10.2 | MAOA; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Major depressive disorder | F32, F33, M32 | MAOA; |
G00-G99: Diseases of the nervous system G00-G99 | Epilepsy | G40 | MAOA; |
G00-G99: Diseases of the nervous system G00-G99 | Neuropathic pain | G64, G90.0 | MAOA; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Depression | F30-F39 | MAOA; |
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | MAOA; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Mood disorder | F30-F39 | MAOA; |
L00-L99: Diseases of the skin and subcutaneous tissue | Vitiligo | L80 | MAOA; |